didodecyldimethylammonium has been researched along with Cancer of Salivary Gland in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Asab, MS; Burton, MA; Cavanagh, HM; Kalle, WH; Morris, JC; Steel, JC; Tsokos, M | 1 |
1 other study(ies) available for didodecyldimethylammonium and Cancer of Salivary Gland
| Article | Year |
|---|---|
Increased tumor localization and reduced immune response to adenoviral vector formulated with the liposome DDAB/DOPE.
Topics: Adenoviridae; Animals; Antibody Formation; beta-Galactosidase; Cell Line, Tumor; Genes, Reporter; Genetic Vectors; Humans; Liposomes; Molecular Conformation; Particle Size; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Rats; Salivary Gland Neoplasms; Tissue Distribution; Transduction, Genetic | 2007 |